About
Jorge Conde is a General Partner at Andreessen Horowitz, where he leads investments at the cross section of biology, computer science, and engineering. Jorge has more than 20 years of experience in leading, building, operating, and investing in life sciences and healthcare, with a broad range of operational roles in early-stage and commercial companies. Prior to joining a16z, Jorge served as Chief Strategy Officer, Chief Financial Officer, and Chief Product Officer for Syros (NASDAQ: SYRS), which is advancing small molecules to control the expression of genes. Jorge was also co-founder and CEO of Knome, a human genome interpretation company acquired by Tute Genomics in 2015. Earlier in his career, Jorge worked in marketing and operations at MedImmune and as a biotechnology investment banker at Morgan Stanley. Jorge holds an MBA from Harvard Business School, an MS from the Harvard-MIT Division of Health Sciences and Technology, and a BA in Biology from Johns Hopkins University. Jorge wa…
Experience
General Partner
Andreessen Horowitz · Silicon Valley
Present
Investing at the cross section of biology, computer science and engineering.
Board Member
Tome Biosciences
Education
Harvard Business School
Master of Business Administration (MBA)
Massachusetts Institute of Technology
Master of Science (MS), Biomedical Enterprise Program
The Johns Hopkins University
Bachelor of Arts (BA), Biology
Find leads like Jorge
Origami finds your ideal customers across 15+ data sources with a single prompt.
Try Origami Free